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Introduction 42 RNA viruses have high mutation rates mainly due to the low fidelity of viral 43 RNA-dependent RNA polymerases (Arnold et al., 2005; Vignuzzi et al., 2008) . This rapid 44 evolution due to high mutation rate usually leads to the generation of genetically and 45 antigenically variable virus strains in the field, which can hinder the development of effective 46 vaccines. Porcine reproductive and respiratory syndrome virus (PRRSV), the causative agent 47 of one of the most economically important global swine diseases, PRRS, has an extremely 48 high mutation rate (Lunney et al., 2010; Murtaugh et al., 2010; Snijder et al., 2013) . 49 Genetically diverse field strains of PRRSV have been constantly emerging over the past two 50 decades since its initial isolation from pigs in 1989 (Murtaugh et al., 2010; Shi et al., 2010a) . 51 PRRSV is currently classified into two distinct genotypes, type 1 and type 2. Within type 2, it 52 is further subdivided into at least 9 distinct genetic lineages (Shi et of an effective vaccine, both major and minor PRRSV envelope proteins should be 86 considered. 87 Molecular breeding through DNA shuffling accelerates gene evolution in vitro by 88 mimicking the natural recombination process in vivo (Crameri et al., 1998; Stemmer, 1994) . 89 Compared to natural recombination, DNA shuffling rapidly generates recombinants with 90 desired phenotypes in vitro (Dupuy et al., 2009; Patten et al., 1997) . In the traditional DNA 91 shuffling approach, a set of target gene fragments derived from parents are digested with 92 DNase I to produce a pool of short DNA fragments, which are then reassembled through PCR 93 amplification to generate a library of recombinants Zhou et al., 2013) . 94 Recombinants with desired properties can then be screened from the library. The DNA 95 shuffling approach has been successfully used to produce more stable and high-yield murine 96 leukemia virus strains, and to broaden cross-neutralizing activities against dengue viruses 97 (Apt et al., 2006; Powell et al., 2000) . In our previous studies, by using molecular breeding 98 through DNA shuffling, we have individually shuffled each of the GP3, GP4, GP5, and M 99 genes of PRRSV (Ni et al., 2013; Zhou et al., 2013; Zhou et al., 2012) . Numerous chimeric 100 viruses were rescued and characterized. For example, chimeric virus DS722 (GP5 shuffled) Following transfection of the full-length chimeric clones into BHK-21 cells, supernatants 140 were harvested after two days (P0 virus) and used to inoculate fresh MARC-145 cells. At 3 to 141 4 days post-inoculation, CPE was observed in inoculated MARC-145 cells, which were 142 subsequently confirmed by IFA using PRRSV N-specific monoclonal antibody, indicative of 143 the production of viable progeny virions and rescue of infectious chimeric viruses ( Fig. 2A ). 144 To further confirm that the rescued progeny viruses originated from the respective transfected viruses FV-SPDS-FV5 and FV-SPDS-VR5 showed similar peak titers to parental virus FV 161 (≈2.5×10 6 TCID 50 /ml), while the FV-SPDS (≈4.0×10 5 TCID 50 /ml) and FV-SPDS-VR2 162 (≈6.3×10 5 TCID 50 /ml) had slightly lower peak titers (<1 log10) compared to FV. The chimera 163 FV-SPDS-VR2 showed an accelerated replication rate, reaching the peak virus titer earlier 164 (≈12 h) than other viruses. 165 To further characterize the growth kinetics of the shuffled chimeric viruses, we also tested 166 virus replication in the cell line ATCC CRL11171, a monkey kidney cell line. Cells were 167 inoculated with P0 chimeric viruses. CPE appeared from 3 to 4 days post-infection, and was 168 verified by IFA using PRRSV-specific antibody (Fig. 2B ). In growth kinetics, both shuffled 169 chimeric and parental viruses (P3) replicated well in ATCC CRL11171 cells ( Fig. 3B ). There 170 was no significant difference in peak infectious virus titers between MARC-145 and ATCC 171 CRL11171 ( Fig. 3C ), although the time points at peak virus titers for most chimeric viruses 172 in ATCC CRL11171 cells were about 12 h later compared to that in MARC-145 cells ( Fig.  9 3A, 3B). Similarly, we observed that the chimera FV-SPDS-FV25 displayed an impaired 174 growth whereas chimera FV-SPDS-VR2 had an accelerated growth rate. Collectively, the 175 results showed that these multiple envelope gene-shuffled chimeric viruses replicated in both 176 MARC-145 and ATCC CRL11171 cells to relatively high titers that are sufficient for use as a To screen for potential viable candidate vaccine strains, we conducted a small pilot animal 182 study by experimentally infecting groups of 3 pigs with one of the five shuffled chimeric 183 viruses or the parental virus to generate antisera specific to each virus. The six groups of pigs 184 inoculated with shuffled viruses or parental virus seroconverted within 14 or 21 dpi and 185 remained seropositive through the end of the study (Fig. 4 ), while the negative control pigs 186 remained seronegative, indicating that all the five multiple envelope gene-shuffled viruses 187 replicated in vivo and elicited immune responses in pigs. One pig in FV group had a very low 188 S/P value compared to the other two pigs, and thus making the overall mean value of FV 189 group lower than other groups. This was likely due to the individual difference caused by the 190 small numbers of pigs (3) used in this pilot study. 191 To assess whether the shuffled chimeric viruses can induce cross-neutralizing antibodies 192 against heterologous PRRSV strains, an SVN assay was performed using serum samples 193 collected at 49 dpi from pigs against parental virus FV as well as five heterologous PRRSV 194 strains belonging to different genetic lineages (Zhou et al., 2013; Zhou et al., 2012) . In the 10 SVN assay against the parental virus FV (Fig. 5A ), the mean NA titers of the FV-SPDS-FV5 196 (5.6) and FV-SPDS-FV25 (5.2) groups were slightly lower than that of the FV group (6.0), 197 while the NA titers of the FV-SPDS, FV-SPDS-VR2, FV-SPDS-VR5 groups were much 198 lower than that of the FV group, likely due to the fact that these three shuffled chimeric 199 viruses contain less envelope protein sequences derived from FV. 200 For the SVN against the heterologous strain VR2430 ( For SVN against the heterologous strain FL12, most serum samples had undetectable NA 211 titers (data not shown). 212 The composite NA titers were generated by combining the individual NA titers against five 213 respective heterologous strains (VR2430, VR2385, NADC20, MN184B, FL12), and analyzed 214 to evaluate the cross-neutralizing ability for each of the five chimeric viruses ( Fig. 5F ).
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Chimeras FV-SPDS-VR2 (P=0.0115) and FV-SPDS-VR5 (P=0.0057) inoculated pigs 216 displayed significantly higher NA titers against heterologous PRRSV strains compared to FV 217 11 inoculated pigs, although the two groups had relatively large error bars due to different titers 218 against different heterologous strain. This suggested that two of shuffled viruses, 219 FV-SPDS-VR2 and FV-SPDS-VR5, had an improved ability to induce cross-neutralizing 220 antibodies in vitro against heterologous PRRSV strains. (Fig. 6B ). 235 At necropsy, both FV-and FV-SPDS-VR2-vaccinated groups showed significantly 236 decreased gross lung lesion scores compared to the non-vaccinated control group when 237 challenged with either NADC20 or MN184B ( Fig. 7A, 7B ). For the NADC20 challenge, the 238 FV-vaccinated group had a lower mean gross lung lesion score than the FV-SPDS-VR2-and 12 FV-SPDS-VR5-vaccinated groups (Fig. 7A ). For the MN184B challenge, the 240 FV-SPDS-VR2-vaccinated group had a numerically lower mean gross lung score than the 241 FV-vaccinated group (FV-SPDS-VR2: 11; FV: 19), although the difference was not 242 statistically significant (P=0.1879, Fig. 7B ). For microscopic lung lesions, both FV-and the 243 two shuffled chimeric viruses-vaccinated groups had significantly lower scores than the 244 non-vaccinated control group when challenged with NADC20 ( Fig. 7C ), but not with 245 MN184B (Fig. 7D ). 246 For the pigs challenged with NADC20, both FV-and chimeric viruses-vaccinated groups 247 had significantly decreased levels of serum viral RNA copies at 7 dpc compared to the 248 non-vaccinated control group (Fig. 8A ). The mean serum PRRSV viral RNA copy number of 249 the FV-SPDS-VR2-vaccinated group (6.3×10 4 copies/ml) was numerically lower than that of 250 the FV-vaccinated group (2.0×10 6 copies/ml), although the difference was not statistically significantly higher cross-neutralizing antibodies against NADC20. However, against the 328 heterologous strains MN184B and FL12, the NA titers of the parental virus FV and all the 5 329 chimeric viruses were very low (<1), and this was somewhat in contrast to our previous 330 studies in which most NA titers were above 1 (Zhou et al., 2013; Zhou et al., 2012) . We 331 speculated that this was largely due to the fact that the virulent strain VR2385 backbone, 332 which was used in our previous studies, can elicit higher levels of neutralizing antibodies 333 against MN184B and FL12 than the vaccine virus FV backbone used in this present study. 334 The data also suggested that the nonstructural proteins may also play roles in inducing NAs, 335 and thus should be considered in the future vaccine design. In general, the NA titer against a 336 particular virus strain was related to the sequence components of the shuffled envelope 337 proteins. For example, compared to other shuffled viruses, FV-SPDS-FV5-and 338 FV-SPDS-FV25-infected pigs developed higher NA titers against FV because the GP2 and/or 339 GP5 of the FV-SPDS-FV5 and FV-SPDS-FV25 viruses were derived from FV (Fig. 1, 5A ). 340 FV-SPDS-VR2-and FV-SPDS-VR5-infected pigs had higher NA titers against VR2385 341 because the GP2 or GP5 of the FV-SPDS-VR2 and FV-SPDS-VR5 viruses were derived 342 from the VR2385 strain ( Fig. 1, 5C ), indicating that GP2 as well as GP5 are important in 343 inducing neutralizing antibody, as GP2 is one of the viral attachment proteins interacting with 344 cellular receptor CD163 (Das et al., 2010) . 345 Although the role of NAs in PRRSV protection is somewhat controversial, the NA titer is when challenged with NADC20 virus, only 1-2 pigs had a high body temperature in the FV-364 or chimeric viruses-vaccinated groups, while 7 pigs developed high body temperature in the 365 unvaccinated/challenged control group (Fig. 6A ). Importantly, both parental FV-and 366 chimeric viruses-vaccinated groups showed significantly lower macroscopic and microscopic 367 lung lesion scores (Fig. 7A, 7C) and lower viral RNA loads in sera and lung tissues ( Fig.   368 8A-C) than the control group. Also, the FV-SPDS-VR2-vaccinated group had numerically 369 lower (but not significantly lower) viral RNA loads relative to the FV-vaccinated group. 370 Together, this data suggest that the two shuffled chimeric viruses and the parental virus 371 provided good protection against heterologous PRRSV strain NADC20 challenge, and it can 372 be hypothesized that the chimera FV-SPDS-VR2 may be well suited to control NADC20 373 viremia by virtue of its NADC20 genetic components. 374 We also included the highly virulent heterologous strain MN184B (lineage 1) as another (Fig. 8F ). Taken together, the data suggest 385 that chimera FV-SPDS-VR2, and parental FV provided partial cross-protection against the 386 highly-virulent heterologous strain MN184B. It was noted that neither parental FV nor 387 chimera FV-SPDS-VR2 induced a high level of NA titers based on SVN assay (Fig. 5E ). 388 Therefore, cellular immune cytokines such as interferon-gamma might also be involved in the 389 protection. Unfortunately, no significant level of interferon gamma was detectable in sera at 0 390 dpc and 14 dpc, and the lack of fresh PBMCs (not collected in this study) prevented us from 391 performing further cytokine testings in this study. 392 In summary, in this study we successfully generated five multiple envelope genes-shuffled nucleotide sequence fragment, designated SPDS, which contains the ORFs 2 through 6. For 433 the SPDS sequence, the GP2 ectodomain-encoding region was derived from strain MN184B, 434 GP3 from chimera GP3TS22, GP4 from chimera GP4TS14, and GP5 from chimera DS722. 435 The entire M sequence was derived from chimera MTS57. The non-ectodomain regions of 436 GP2 through 5 were from pFV. The overlapping sequences of ORFs 2-3 were derived from 437 chimera GP3TS22, and the overlapping sequences of ORFs 3-4 were from chimera GP4TS14. 438 The genomic organizations of the chimeric virus constructs are depicted in Fig. 1 . fixed in 10% neutral-buffered formalin and processed for histopathology evaluation. Fresh 548 lung tissues were also collected and stored at -80°C for quantification of viral RNA loads by 549 RT-qPCR. 550 The criteria for evaluating the gross pathology and histopathology have been well 551 established and described previously (Halbur et al., 1995; Ni et al., 2013) . 
